Google DeepMind launches AI tool to help identify genetic drivers of disease
Researchers at Google DeepMind have unveiled their latest artificial intelligence tool and claimed it will help scientists identify the genetic drivers of disease and ultimately pave the way for new treatments. AlphaGenome predicts how mutations interfere with the way genes are controlled, changing when they are switched on, in which cells of the body, and whether their biological volume controls are set to high or low. Most common diseases that run in families, including heart disease and autoimmune disorders,…
AlphaGenome analyzes up to 1m letters of DNA to predict how non-coding mutations alter gene regulation across cell types, helping researchers pinpoint genetic drivers of disease and design targeted DNA sequences.
Evidence
- JournalismThe Guardian2026-01-28
How should this claim be treated?
Truvace Impact Record TRV-2026-0213, v1: “Google DeepMind launches AI tool to help identify genetic drivers of disease.” Truvace, 2026-07-14. /record/TRV-2026-0213 (accessed at citation time). sha256 923750e4a0173473…
Calibration history
Every change to this record since certification, in the open. None yet — the reading has held since it entered the record.
Certified into the record
How to verify without trusting this page
Fetch the canonical text of any version from /api/record/TRV-2026-0213 and hash it yourself — for example shasum -a 256 on the saved canonical field. The result must equal content_hash, and each version’s text ends with prev:followed by the prior version’s hash (version 1 chains to 64 zeros). If a single character of any version had been altered since certification, the chain would not reproduce.
ace